Reimel v. MacFarlane

9 F. Supp. 2d 1062, 1998 U.S. Dist. LEXIS 9361, 1998 WL 338247
CourtDistrict Court, D. Minnesota
DecidedJune 23, 1998
DocketCivil 97-1553(JRT/RLE)
StatusPublished
Cited by6 cases

This text of 9 F. Supp. 2d 1062 (Reimel v. MacFarlane) is published on Counsel Stack Legal Research, covering District Court, D. Minnesota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Reimel v. MacFarlane, 9 F. Supp. 2d 1062, 1998 U.S. Dist. LEXIS 9361, 1998 WL 338247 (mnd 1998).

Opinion

MEMORANDUM OPINION AND ORDER GRANTING DEFENDANTS’ MOTION TO DISMISS

TUNHEIM, District Judge.

This matter is before the Court on defendants’ motion to dismiss this shareholder derivative action on the ground that the plaintiff failed to make a demand on defendant Otter Tail Power Company’s (“Otter Tail”) board of directors and failed to articulate why she is excused from the demand requirement. In the alternative, defendants move to certify the question of demand futility to the Minnesota Supreme Court. For the reasons set forth below, defendants’ motion to dismiss is granted, and plaintiff’s claims are dismissed without prejudice.

BACKGROUND 1

Otter Tail, a corporation formed under the laws of Minnesota, is a public utility that is also engaged in other lines of business *1064 through subsidiaries. Defendants John C. MacFarlane, Thomas W. Brown, Dayle Dietz, Dennis R. Emmen, Maynard D. Helgaas, Arvid R. Liebe, Kenneth L. Nelson, Nathan I. Partain, and Robert N. Spolum are directors of Otter Tail, and defendants MacFarlane, Richard W. Muehlhausen, Douglas L. Kjellerup, Jay D. Myster, Ward L. Uggerud, and A.E. Anderson are officers of Otter Tail.

As of May 1, 1997, Otter Tail had over eleven million common shares outstanding. These shares are traded actively on the NASDAQ market. Plaintiff Patricia C. Reimel is an owner of an undisclosed number of shares of Otter Tail stock.

On January 27, 1997, Otter Tail adopted a “Shareholder Rights Plan” (“the Plan”). In a news release issued that day, Otter Tail’s spokesperson stated that the Plan provides protection against hostile takeovers but disclaimed the existence of any specific takeover bid.

This Plan created a new class of Otter Tail securities, the “Preferred Share Purchase Rights” (the “Rights”). The Rights were declared and became payable as a dividend, one Right per share for each of the outstanding common shares of the company on the record date of February 7,1997.

The Rights contain a “flip-in” provision, which entitles each holder of a Right to buy $140 worth of Otter Tail shares for $70 upon any number of triggering events relating to the acquisition of fifteen percent or more of Otter Tail’s common stock. This provision deters would be acquirers of Otter Tail by threatening to dilute their holdings and greatly increase the number of shares an acquirer would have to purchase in order to consummate a merger, combination, or takeover purchase.

The Rights also contain a “flip-over” feature, providing that, in the event of a hostile takeover or merger, the shareholders may purchase $100 worth of the acquiring company’s shares for $50. This feature subjects the acquiring company to a half-price sale of its own stock and thereby dilutes the interest of its other shareholders, obviously deterring potential acquisitions.

Neither the “flip-in” nor “flip-over” provisions — also known individually and collectively as a “poison pill” — apply if an offer for all Otter Tail shares has been approved by a majority of the company’s non-officer directors. Also, these rights can be voided by Otter Tail’s so-called “Continuing Directors,” persons who were members of the Board of Directors on or before January 27, 1997 or successors approved by a majority of the incumbent Continuing Directors.

Finally, the Plan contains a so-called “dead hand” feature, which provides that flip-in or flip-over rights, once exercisable, remain exercisable until January 27, 2007 or until their earlier redemption by a majority of the Continuing Directors. Any redemption is at the option of the Continuing Directors and on such basis and with such conditions as they, in their discretion, may establish.

Plaintiff alleges the dead hand feature serves no purpose other than to discourage future acquisition activities by making proxy contests to replace members of the current board of directors absolutely futile. It disenfranchises shareholders by forcing them to vote for incumbent directors or their desig-nees if they want to be represented by a board entitled to exercise its full prerogatives. In other words, by limiting the power to redeem the poison pill to Continuing Directors, the dead hand severely handicaps future boards to the point of rendering future contests for corporate control prohibitively expensive and effectively impossible. This “entrenches” the incumbent board by preventing the shareholders — who never approved the Rights — from receiving any offer to purchase their shares without the prior approval of the Continuing Directors.

Plaintiffs derivative action seeks to invalidate the Plan as unlawful per se, as a whole or to the extent of its dead hand provision. The Complaint also includes claims against the director defendants for breach of fiduciary duty and against the officer defendants for aiding and abetting them. It further states that plaintiff has not made a demand on Otter Tail’s board because such a demand would be futile. Specifically, the Complaint alleges a demand would be futile because the entire board approved the Plan, because the director defendants are interested parties and cannot make a truly independent decision whether to commence an action against *1065 themselves, and because the director defendants cannot defend their actions as any type of independent business judgment since their actions were for the purpose of entrenching themselves in their current positions.

At this stage of the litigation, defendants do not dispute that the Plan contains the poison pill and dead hand provisions. They do deny, however, plaintiffs’ claim that the Plan was designed to entrench the current directors, and they contend their actions were a legitimate exercise of business judgment. Finally, defendants reject plaintiffs’ futility allegations as conelusory and insufficient and argue, to the contrary, that such a demand would not be futile in this context.

ANALYSIS

Federal Rule of Civil Procedure 23.1 requires that, in a derivative action brought by a shareholder to enforce a right of a corporation, the complaint allege with particularity “the efforts, if any, made by the plaintiff to obtain the action plaintiff desires from the directors or comparable authority and ... the reasons for plaintiffs failure to obtain the action or for not making the effort.” Because there is no dispute that plaintiff failed to make a demand upon the Otter Tail board, the issue in this ease is whether such a demand is excused under Minnesota law. 2

In Minnesota and elsewhere, demand is excused if it would be futile. See, e.g., Winter v. Farmers Educ. and Coop. Union, 259 Minn. 257, 107 N.W.2d 226, 233-34 (1961); Aronson v. Lewis, 473 A.2d 805, 814 (Del.1984). Courts in some jurisdictions have outlined clear prerequisites for finding futility.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Hopson v. Singh
E.D. California, 2019
In re Medtronic, Inc. Derivative Litigation
68 F. Supp. 3d 1054 (D. Minnesota, 2014)
Kococinski ex rel. Medtronic, Inc. v. Collins
935 F. Supp. 2d 909 (D. Minnesota, 2013)
In Re Patterson Companies, Inc. Securities
479 F. Supp. 2d 1014 (D. Minnesota, 2007)
In re AFC Enterprises, Inc. Derivative Litigation
224 F.R.D. 515 (N.D. Georgia, 2004)
Fujimoto v. Au
19 P.3d 699 (Hawaii Supreme Court, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
9 F. Supp. 2d 1062, 1998 U.S. Dist. LEXIS 9361, 1998 WL 338247, Counsel Stack Legal Research, https://law.counselstack.com/opinion/reimel-v-macfarlane-mnd-1998.